fWe previously showed that the orphan nuclear receptor Nur77 (Nr4a1) plays an important role in the regulation of glucose homeostasis and oxidative metabolism in skeletal muscle. Here, we show using both gain-and loss-of-function models that Nur77 is also a regulator of muscle growth in mice. Transgenic expression of Nur77 in skeletal muscle in mice led to increases in myofiber size. Conversely, mice with global or muscle-specific deficiency in Nur77 exhibited reduced muscle mass and myofiber size. In contrast to Nur77 deficiency, deletion of the highly related nuclear receptor NOR1 (Nr4a3) had minimal effect on muscle mass and myofiber size. We further show that Nur77 mediates its effects on muscle size by orchestrating transcriptional programs that favor muscle growth, including the induction of insulin-like growth factor 1 (IGF1), as well as concomitant downregulation of growth-inhibitory genes, including myostatin, Fbxo32 (MAFbx), and Trim63 (MuRF1). Nur77-mediated increase in IGF1 led to activation of the Akt-mTOR-S6K cascade and the inhibition of FoxO3a activity. The dependence of Nur77 on IGF1 was recapitulated in primary myoblasts, establishing this as a cell-autonomous effect. Collectively, our findings identify Nur77 as a novel regulator of myofiber size and a potential transcriptional link between cellular metabolism and muscle growth.
Skeletal muscle serves indelible roles in mediating locomotion and postural tone, as well as in the maintenance of energy homeostasis. Muscle wasting is commonly observed in patients with primary neuromuscular pathologies as well as in those with cancer cachexia. Much underappreciated, however, is the vast number of people who develop muscle atrophy as a comorbidity of aging, disuse, diabetes, heart failure, and chronic inflammatory illnesses. Muscle loss not only impairs the activities of daily living but also increases the risk of developing diabetes and of mortality (1-4). Current approaches of mitigating muscle loss-nutritional support and exercise-may be insufficient or infeasible in certain patient populations. Understanding the fundamental signaling pathways that control muscle mass is thus paramount to the development of novel therapies.Maintenance of muscle mass in the adult animal depends largely on the balance of signals that favor growth or atrophy. Environmental cues, including protein excess, growth factors, physical exercise, and â€-adrenergic stimulation, activate a complex array of overlapping signaling pathways affecting muscle homeostasis (5, 6). The most well known pathway, the insulin-like growth factor 1 (IGF1)-Akt-mTOR cascade, promotes protein synthesis through concurrent regulation of multiple components of the translational machinery. Muscle differentiation and growth are also modulated by mitogen-activated protein kinases (MAPKs) including extracellular signal-regulated kinase 1 and 2 (ERK1/2) and p38, which can be activated by calcium as well as calciumindependent pathways (7-11). PGC1âŁ4 has also been shown to be a mediator of exercise-induced...